Page 3 of 18 SEC Filing CUSIP No. 67552A108 Page 3 of 18
1. Name of reporting persons VHCP Co-Investment Holdings, LLC 2. Check the appropriate box if a member of a group (see instructions) (a) x1 (b) ¨ 3. SEC use only 4. Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: 5. Sole voting power 0 6. Shared voting power 1,885,6682 7. Sole dispositive power 0 8. Shared dispositive power 1,885,6682 9. Aggregate amount beneficially owned by each reporting person 1,885,6682 10. Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ 11. Percent of class represented by amount in Row (9) 9.1%3 12. Type of reporting person (see instructions) OO
1 Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G.
2 Consists of (i) 792,351 shares of common stock owned by Venrock Healthcare Capital Partners, L.P., including 118,981 shares underlying immediately exercisable warrants; (ii) 144,945 shares of common stock owned by VHCP Co-Investment Holdings, LLC, including 21,765 shares underlying immediately exercisable warrants; (iii) 674,803 shares of common stock owned by Venrock Healthcare Capital Partners II, L.P.; and (iv) 273,569 shares of common stock owned by VHCP Co-Investment Holdings II, LLC.
3 This percentage is calculated based upon 20,503,211 shares of common stock outstanding as of October 31, 2015, as set forth in Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015.
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. 67552A108 | Page 3 of 18 |
| 1. | Name of reporting persons VHCP Co-Investment Holdings, LLC | |||||
| 2. | Check the appropriate box if a member of a group (see instructions) (a) x1 (b) ¨ | |||||
| 3. | SEC use only | |||||
| 4. | Citizenship or place of organization Delaware | |||||
| Number of shares beneficially owned by each reporting person with: | | 5. | | Sole voting power 0 | ||
| | 6. | | Shared voting power 1,885,6682 | |||
| | 7. | | Sole dispositive power 0 | |||
| | 8. | | Shared dispositive power 1,885,6682 | |||
| 9. | Aggregate amount beneficially owned by each reporting person 1,885,6682 | |||||
| 10. | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ | |||||
| 11. | Percent of class represented by amount in Row (9) 9.1%3 | |||||
| 12. | Type of reporting person (see instructions) OO | |||||
| 1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G. |
| 2 | Consists of (i) 792,351 shares of common stock owned by Venrock Healthcare Capital Partners, L.P., including 118,981 shares underlying immediately exercisable warrants; (ii) 144,945 shares of common stock owned by VHCP Co-Investment Holdings, LLC, including 21,765 shares underlying immediately exercisable warrants; (iii) 674,803 shares of common stock owned by Venrock Healthcare Capital Partners II, L.P.; and (iv) 273,569 shares of common stock owned by VHCP Co-Investment Holdings II, LLC. |
| 3 | This percentage is calculated based upon 20,503,211 shares of common stock outstanding as of October 31, 2015, as set forth in Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015. | ||
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
